Rabeprazole Chloride Compound CAS 153259-31-5 Asssay >99.5% (HPLC) Factory
Ruifu Chemical Supple Rabeprazole Sodium Intermedia
Rabeprazole Sodium CAS 117976-90-6
Rabeprazole Hydroxy Compone CAS 675198-19-3
Rabeprazole Chloride Compone CAS 153259-31-5
Nomen chemicum | 2-Chloromethyl-3-Methyl-4-(3-Methoxypropoxy)pyridinum hydrochloridum |
Synonyma | Rabeprazole Chloride Compound;Rabeprazole Chloro Compound;Rabeprazole 2-Chloromethyl Impurity;4-(3-Methoxypropoxy) -2-(Chloromethyl) |
CAS Number | 153259-31-5 |
CATTUS Number | RF-PI1918 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C11H17Cl2NO2 |
M. Pondus | 266.16 |
Liquescens punctum | 113.0~115.0℃ |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Yellow ad Off-White Crystalline pulveris |
Asssay / Analysis Methodo | >99.5% (HPLC) |
Damnum in Siccatio | <0.50% |
Aquae (KF) | <0.50% |
Residere in Ignition | <0.20% |
Unam immunditiam | <0.50% |
Totalis immunditias | <0.50% |
Metalla gravis | <20ppm |
Test Standard | Enterprise Standard |
Consuetudinem | Medium Rebeprazole Sodium (CAS: 117976-90-6) |
Rabeprazole Chloride Compone CAS 153259-31-5 Syntheticum Route
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
2-Chloromethyl-3-Methyl-4-(3-Methoxypropoxydum hydrochloridum, Rabeprazole Chloride Compositum (CAS: 153259-31-5) medium est Sodium Rebeprazole (CAS: 117976-90-6).Rabeprazole Sodium est anti-morbus ulceris medicamentum ad sentinam protonom inhibitoris pertinens et est forma salis sodium Rabeprazole.Societates Iaponicae Eisai eam primum feliciter enucleaverunt cum nomine artis "Bolite".Munus sentinae inhibitorum protonatorum minuit secretionem acidi gastrici ita ut situs laesio stabilis esse possit ad effectum medendi ulcera gastrica et duodena et refluxus stomachi morbus.Amet in curatione morborum acidorum relatarum, ut ventriculi et ulcera duodena, ulceris peptici, gastroesophagi morbi refluxus et zollinger-ellison syndrome.Rabeprazole est genus compositorum benzimidazole substitutum.Secretionem acidi gastrici inhibet per sentinam cum cytoplasmico formando vinculo in pariete cavitatis gastricae.Productum hoc specialiter inhibere potest effectum triphosphatasis adenosinae, quae est clavis enzyme in productione acidi stomachi.Effectum inhibitorium habet in acido basali gastrico et in acido gastrico secretionis excitandae causata.